Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mammography screening and false positives

This article was originally published in The Gray Sheet

Executive Summary

Physicians who counsel women about breast cancer screening need to convey that the cumulative risk of a false positive is nearly 50% after 10 mammograms and 22% after 10 clinical breast examinations, Joann Elmore, MD/MPH, University of Washington School of Medicine, et al., conclude in a study published in the April 16 New England Journal of Medicine. Measures should be developed to minimize the associated psychological and economic costs of false positives; one suggested method is to use on-site radiologists to obtain immediate work-ups rather than requiring women to return for follow-up diagnostic procedures. The conclusions are based on a 10-year, retrospective cohort study of 2,400 women age 40-69 enrolled at a large New England HMO in which a total of 9,762 screening mammograms and 10,905 clinical breast examinations were performed. Researchers found the risk of false positives to be higher in the 40-49 group than for women 50 and older

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel